Ventral striatal activation during reward processing in psychosis a neurofunctional meta-analysis

JAMA Psychiatry

Volumn 72, Issue 12, 2015, Pages 1243-1251

  Radua, Joaquim ^a,b   Schmidt, Andre ^a,c   Borgwardt, Stefan ^a,c   Heinz, Andreas ^d,e   Schlagenhauf, Florian ^d,e   McGuire, Philip ^a   Fusar Poli, Paolo ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITY OF BASEL   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e MAX PLANCK INSTITUTE FOR HUMAN COGNITIVE AND BRAIN SCIENCES   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICIPATION; ARTICLE; BRAIN FUNCTION; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; PREDICTION; REWARD; SCHIZOPHRENIA; SIMULATION; SYSTEMATIC REVIEW; VENTRAL STRIATUM; ADULT; CASE CONTROL STUDY; FEMALE; FUNCTIONAL NEUROIMAGING; MALE; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PSYCHOSIS; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PSYCHOTIC DISORDERS; REWARD; VENTRAL STRIATUM; YOUNG ADULT;

EID: 84948973607     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2196     Document Type: Article

References (77)

1. McGhie A, Chapman J. Disorders of attention and perception in early schizophrenia. Br J Med Psychol. 1961; 34: 103-116.
2. Chapman J. The early symptoms of schizophrenia. Br J Psychiatry. 1966; 112 (484): 225-251.
3. Miller R. Schizophrenic psychology, associative learning and the role of forebrain dopamine. Med Hypotheses. 1976; 2 (5): 203-211.
4. Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003; 160 (1): 13-23.
5. Heinz A. Dopaminergic dysfunction in alcoholism and schizophrenia-psychopathological and behavioral correlates. Eur Psychiatry. 2002; 17 (1): 9-16.
6. Berridge KC, Robinson TE. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev. 1998; 28 (3): 309-369.
7. Heinz A, Schlagenhauf F. Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull. 2010; 36 (3): 472-485.
8. Fletcher PC, Frith CD. Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat Rev Neurosci. 2009; 10 (1): 48-58.
9. SchultzW, Apicella P, Scarnati E, Ljungberg T. Neuronal activity in monkey ventral striatum related to the expectation of reward. J Neurosci. 1992; 12 (12): 4595-4610.
10. SchultzW, Dayan P, Montague PR. A neural substrate of prediction and reward. Science. 1997; 275 (5306): 1593-1599.
11. Lodge DJ, Grace AA. Hippocampal dysregulation of dopamine system function and the pathophysiology of schizophrenia. Trends Pharmacol Sci. 2011; 32 (9): 507-513.
12. Winton-Brown TT, Fusar-Poli P, Ungless MA, Howes OD. Dopaminergic basis of salience dysregulation in psychosis. Trends Neurosci. 2014; 37 (2): 85-94.
13. Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F/11C]-DOPA PET studies. Schizophr Bull. 2013; 39 (1): 33-42.
14. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry. 2012; 69 (8): 776-786.
15. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl). 2006; 187 (2): 222-228.
16. Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage. 2006; 29 (2): 409-416.
17. Schlagenhauf F, Juckel G, Koslowski M, et al. Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology (Berl). 2008; 196 (4): 673-684.
18. Schlagenhauf F, Sterzer P, Schmack K, et al. Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry. 2009; 65 (12): 1032-1039.
19. Diaconescu AO, Jensen J, Wang H, et al. Aberrant effective connectivity in schizophrenia patients during appetitive conditioning. Front Hum Neurosci. 2011; 4: 239.
20. Esslinger C, Englisch S, Inta D, et al. Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. Schizophr Res. 2012; 140 (1-3): 114-121.
21. Hägele C, Schlagenhauf F, Rapp M, et al. Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders. Psychopharmacology (Berl). 2015; 232 (2): 331-341.
22. Grimm O, Heinz A, Walter H, et al. Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia. JAMA Psychiatry. 2014; 71 (5): 531-539.
23. de Leeuw M, Kahn RS, VinkM. Fronto-striatal dysfunction during reward processing in unaffected siblings of schizophrenia patients. Schizophr Bull. 2015; 41 (1): 94-103.
24. Nielsen MØ, Rostrup E, Wulff S, et al. Alterations of the brain reward system in antipsychotic naïve schizophrenia patients. Biol Psychiatry. 2012; 71 (10): 898-905.
25. Nielsen MO, Rostrup E, Wulff S, et al. Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia. Arch Gen Psychiatry. 2012; 69 (12): 1195-1204.
26. Walter H, Kammerer H, Frasch K, Spitzer M, Abler B. Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia. Psychopharmacology (Berl). 2009; 206 (1): 121-132.
27. Simon JJ, Biller A, Walther S, et al. Neural correlates of reward processing in schizophrenia-relationship to apathy and depression. Schizophr Res. 2010; 118 (1-3): 154-161.
28. Waltz JA, Schweitzer JB, Ross TJ, et al. Abnormal responses to monetary outcomes in cortex, but not in the basal ganglia, in schizophrenia. Neuropsychopharmacology. 2010; 35 (12): 2427-2439.
29. Dowd EC, Barch DM. Pavlovian reward prediction and receipt in schizophrenia: relationship to anhedonia. PLoS One. 2012; 7 (5): e35622.
30. Mucci A, Dima D, Soricelli A, et al. Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? a functional magnetic resonance imaging study during reward anticipation and feedback. Psychol Med. 2015; 45 (8): 1765-1778.
31. Gilleen J, Shergill SS, Kapur S. Impaired subjective well-being in schizophrenia is associated with reduced anterior cingulate activity during reward processing. Psychol Med. 2015; 45 (3): 589-600.
32. Roiser JP, Howes OD, Chaddock CA, Joyce EM, McGuire P. Neural and behavioral correlates of aberrant salience in individuals at risk for psychosis. Schizophr Bull. 2013; 39 (6): 1328-1336.
33. Wotruba D, Heekeren K, Michels L, et al. Symptom dimensions are associated with reward processing in unmedicated persons at risk for psychosis. Front Behav Neurosci. 2014; 8: 382.
34. Juckel G, Friedel E, Koslowski M, et al. Ventral striatal activation during reward processing in subjects with ultra-high risk for schizophrenia. Neuropsychobiology. 2012; 66 (1): 50-56.
35. Abler B, Greenhouse I, Ongur D, Walter H, Heckers S. Abnormal reward system activation in mania. Neuropsychopharmacology. 2008; 33 (9): 2217-2227.
36. da Silva Alves F, Bakker G, Schmitz N, et al. Dopaminergic modulation of the reward system in schizophrenia: a placebo-controlled dopamine depletion fMRI study. Eur Neuropsychopharmacol. 2013; 23 (11): 1577-1586.
37. Smieskova R, Roiser JP, Chaddock CA, et al. Modulation of motivational salience processing during the early stages of psychosis. Schizophr Res. 2015; 166 (1-3): 17-23.
38. Murray GK, Corlett PR, Clark L, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008; 13 (3): 239, 267-276.
39. Waltz JA, Schweitzer JB, Gold JM, et al. Patients with schizophrenia have a reduced neural response to both unpredictable and predictable primary reinforcers. Neuropsychopharmacology. 2009; 34 (6): 1567-1577.
40. Gradin VB, Kumar P, Waiter G, et al. Expected value and prediction error abnormalities in depression and schizophrenia. Brain. 2011; 134 (pt 6): 1751-1764.
41. Morris RW, Vercammen A, Lenroot R, et al. Disambiguating ventral striatum fMRI-related BOLD signal during reward prediction in schizophrenia. Mol Psychiatry. 2012; 17 (3): 235, 280-289.
42. Schlagenhauf F, Huys QJ, Deserno L, et al. Striatal dysfunction during reversal learning in unmedicated schizophrenia patients. Neuroimage. 2014; 89: 171-180.
43. Koch K, Schachtzabel C, Wagner G, et al. Altered activation in association with reward-related trial-and-error learning in patients with schizophrenia. Neuroimage. 2010; 50 (1): 223-232.
44. Wolf DH, Satterthwaite TD, Kantrowitz JJ, et al. Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures. Schizophr Bull. 2014; 40 (6): 1328-1337.
45. Gibson CA, Bailey BW, Carper MJ, et al. Author contacts for retrieval of data for ameta-analysis on exercise and diet restriction. Int J Technol Assess Health Care. 2006; 22 (2): 267-270.
46. Stroup DF, Berlin JA, Morton SC, et al; Meta-analysis of Observational Studies in Epidemiology (MOOSE) group.Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283 (15): 2008-2012.
47. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization; 1992.
48. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.
49. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013; 70 (1): 107-120.
50. Johnstone EC, Abukmeil SS, ByrneM, et al. Edinburgh high risk study-findings after four years: demographic, attainment and psychopathological issues. Schizophr Res. 2000; 46 (1): 1-15.
51. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339: b2535.
52. Radua J, Rubia K, Canales-Rodríguez EJ, Pomarol-Clotet E, Fusar-Poli P, Mataix-Cols D. Anisotropic kernels for coordinate-based meta-analyses of neuroimaging studies. Front Psychiatry. 2014; 5: 13.
53. Radua J, Mataix-Cols D, PhillipsML, et al. A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. Eur Psychiatry. 2012; 27 (8): 605-611.
54. Desikan RS, Ségonne F, Fischl B, et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006; 31 (3): 968-980.
55. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York, NY: John Wiley and Sons; 1987.
56. ViechtbauerW. Conductingmeta-analyses in R with themetafor package. J Stat Softw. 2010; 36 (3): 1-48.
57. Li KH, Meng XL, Raghunathan TE, Rubin DB. Significance levels from repeated p-values with multiply-imputed data. Stat Sin. 1991; 1 (1): 65-92.
58. Fusar-Poli P, Radua J, Frascarelli M, et al. Evidence of reporting biases in voxel-based morphometry (VBM) studies of psychiatric and neurological disorders. Hum Brain Mapp. 2014; 35 (7): 3052-3065.
59. David SP, Ware JJ, Chu IM, et al. Potential reporting bias in fMRI studies of the brain. PLoS One. 2013; 8 (7): e70104.
60. Ioannidis JP, MunafòMR, Fusar-Poli P, Nosek BA, David SP. Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention. Trends Cogn Sci. 2014; 18 (5): 235-241.
61. Deserno L, Boehme R, Heinz A, Schlagenhauf F. Reinforcement learning and dopamine in schizophrenia: dimensions of symptoms or specific features of a disease group? Front Psychiatry. 2013; 4: 172.
62. Fusar-Poli P, Meyer-Lindenberg A. Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull. 2013; 39 (1): 22-32.
63. Kegeles LS, Abi-Dargham A, FrankleWG, et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry. 2010; 67 (3): 231-239.
64. Egerton A, Chaddock CA, Winton-Brown TT, et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry. 2013; 74 (2): 106-112.
65. Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des. 2009; 15 (22): 2550-2559.
66. Singh KD. Which "neural activity" do you mean? fMRI, MEG, oscillations and neurotransmitters. Neuroimage. 2012; 62 (2): 1121-1130.
67. Schott BH, Minuzzi L, Krebs RM, et al. Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release. J Neurosci. 2008; 28 (52): 14311-14319.
68. Urban NB, SlifsteinM, Meda S, et al. Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging. Psychopharmacology (Berl). 2012; 221 (1): 67-77.
69. Deserno L, Huys QJ, Boehme R, et al. Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decisionmaking. ProcNatl Acad Sci U S A. 2015; 112 (5): 1595-1600.
70. Schlagenhauf F, Rapp MA, Huys QJ, et al. Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligence. Hum Brain Mapp. 2013; 34 (6): 1490-1499.
71. Pankow A, Katthagen T, Diner S, et al. Aberrant salience is related to dysfunctional self-referential processing in psychosis. Schizophr Bull. 2015; sbv098.
72. Boehme R, Deserno L, Gleich T, et al. Aberrant salience is related to reduced reinforcement learning signals and elevated dopamine synthesis capacity in healthy adults. J Neurosci. 2015; 35 (28): 10103-10111.
73. Goghari VM, Sponheim SR, MacDonald AW. The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev. 2010; 34 (3): 468-486.
74. Blanchard JJ, Cohen AS. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull. 2006; 32 (2): 238-245.
75. Fusar-Poli P, Papanastasiou E, Stahl D, et al. Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015; 41 (4): 892-899.
76. Knutson B, Fong GW, Bennett SM, Adams CM, Hommer D. A region of mesial prefrontal cortex tracks monetarily rewarding outcomes: characterization with rapid event-related fMRI. Neuroimage. 2003; 18 (2): 263-272.
77. RothkirchM, Schmack K, Deserno L, Darmohray D, Sterzer P. Attentional modulation of reward processing in the human brain. Hum Brain Mapp. 2014; 35 (7): 3036-3051.